Mr
Stephen J H Miller (London) read a paper which concerned the ophthalmological aspects of neurofibromatosis, von Hippel-Lindau disease, Bourneville's disease, the lipidoses, retinitis pigmentosa, sarcoidosis, toxoplasmosis, toxocara infestation and cytomegalic inclusion disease. The paper was illustrated by many coloured photographs of the ocular fundus.
Meeting May 61965 Localization of Cerebral Lesions by Radioactive Isotopes and Ultrasound [Abridged] Dr James Bull (Institute of Neurology, National Hospital, London) At Queen Square we have now been scanning patients for just on two years and have undertaken a little over 700 examinations. During this time we have used four different isotopes and no one of them has been outstandingly the best in producing results. However, we have no doubt in our minds that the isotope 197Hg is the best available at the moment from the point of view of radiation hazard; it gives a negligible dose to the kidneys, something under 1 rad, while 203Hg, for example, gives about 50 rads. In our view the use of 203Hg should be very much restricted.
However, it has one great advantage: its half life is sufficiently long to permit it to be stored in the Department for two or three weeks and without too much decay. Thus, it can be available for emergency cases at times like weekends. 197Hg must be used in the first few days as its decay is so rapid. Dr Marryat and I recently published the results of our first 100 examinations (Bull & Marryat 1965) . Subsequent experience has not caused us to change our views. Like others we have found that three of the commonest tumour types nearly always accept the isotope. These groups are: malignant astrocytoma, meningioma and metastasis.
Factors limiting the value of the method are: (1) Masses of less than 2 cm diameter can seldom be demonstrated. This is a biophysical problem and one hopes that in time more sensitive apparatus will be designed to overcome it.
(2) Most benign astrocytomas and most pituitary tumours fail to take up isotopes to a greater degree than normal brain tissue and thus cannot be demonstrated.
(3) Muscles and air sinuses and mastoid cells accept the isotope much more readily than brain tissue and so tumours at the base of the skull are only demonstrable if they take up the isotope with avidity. This applies, for example, to acoustic neuromas.
Granted that the isotope is usually accepted by most malignant astrocytomas, meningiomas and metastases (which are all beyond the critical diameter of size) sufficiently to cast a definite shadow on the photographic film, and granted that benign astrocytomas, pituitary tumours and acoustic neuromas can seldom be demonstrated, it must be agreed that there is a very small percentage of intracranial tumours which remain.
Having demonstrated and localized the lesion, the next question is to what extent its anatomical relations and pathology can be defined. Just as masses can be localized and sometimes labelled pathologically by pneumography, depending upon the ventricular and cisternal patterns; and similarly by angiography the position of lesions can be deduced by arterial and venous displacement and the pathology predicted by noting abnormal vascular patterns; so we should have criteria for determining the pathology by means -of isotope scanning.
It must be recognized that scanning is a diagnostic radiological method, but it has come only recently into the hands of radiologists. We have found that by applying radiological principles it is possible to predict accurately the morbid anatomical changes in a proportion of cases. With isotope encephalography our landmarks are naturally different. They are not the cerebrospinal fluid pathways or the blood vessels, but the convexity dura, the falx, the tentorium and corpus callosum. By noting the relations of isotope uptake to these structures, one can make useful deductions.
Astrocytomas represent about 50% of intracranial neoplasms. Nearly all malignant astrocytomas (Grades III & IV on the Kernohan classification) accept the isotope sufficiently to enable one to demonstrate the lesion readily on a scan. Our experience, shared by others, shows that the more benign astrocytomas very often fail to accept the isotope and so far nearly all scans on calcified astrocytomas, which tend to be benign, have been negative. However, the great majority of astrocytomas are of the more malignant grades. This is the usual experience and Betty (1964) found that 78 *4 % of 342 astrocytomas seen in Sheffield between 1950 and 1958 were malignant histologically.
Astrocytomas involving the corpus callosum are readily demonstrable by isotope encephalographyfar more readily than by either air studies or angiography. This is one of the pathological conditions which can be specifically diagnosed by isotopes. The diagnosis can be made so confidently that in our view biopsy becomes redundant. By their very nature many astrocytomas infiltrate the brain extensively without distorting the ventricular structures or main arteries; it is therefore not surprising that, in a number of cases in which angiograms and pneumograms have been negative, the isotope scans have been positive. This represents a very real advance in radiological diagnosis. The frequent involvement of the corpus callosum by malignant astrocytomas is well known. In 1957 Bull & Rovit studied 100 autopsy-confirmed cases of astrocytoma, with the object of defining the accuracy of pneumography and angiography regarding the position and extent of the tumours. One-third invaded the corpus callosum. In our first 100 scans there were 22 astrocytomas of malignant grade and no fewer than 8 were shown on the scan to involve the corpus callosum. This was a most striking improvement in diagnostic accuracy compared with pneumography and angiography. Astrocytomas not involving the corpus callosum can often be predicted by scanning. Their shadow tends to have an unsharp edge and they are usually not related to the falx or convexity dura.
Meningiomas: The large majority of meningiomas exceed the critical diameter of 2 cm by the time they cause symptoms and signs. Exceptions, of course, immediately come to mind such as those in the suprasellar region which can evoke severe signs and symptoms when as small as a pea. Again, not very large meningiomas in the cerebellopontine angle cistern can evoke serious disease. But large meningiomas, both supra-and infra-tentorial readily take up the isotope in over 90 % of cases. It must be stressed that the method is not entirely infallible and we failed to demonstrate one large parietal meningioma in our first 100 examinations.
Metastases: Provided these tumours exceed a diameter of 2 cm they usually can be shown. So far as we know we have never failed to demonstrate a metastasis larger than the critical diameter. But as can be appreciated one often fails to get permission for autopsy confirmation. Our firm impression is that multiple metastases can be more readily demonstrated by this means than by either pneumography or angiography, and the presence of multiple masses is nearly always indicative of metastases.
Non-tumorous lesions: There are three groups in particular to consider: (1) Abscesses, which accept isotopes with avidity and this is obviously of great clinical importance; we have had only two cases (both positive) but Planiol (1963) claims an accuracy of 100% (18 out of 18 cases).
(2) Subdural hnmatomas: these are also readily picked up. (3) Intracerebral hmmatomas and infarcts: our experience is too limited as yet to give an authoritative opinion on the frequency with which such lesions can be demonstrated and with what accuracy one can differentiate the one type from the other. Improvement ofPathological Diagnosis by Isotope Encephalography For the last ten years Professor Planiol of Paris has been using a technique which consists basically in recording the degree of uptake of the isotope in a given mass over time. Thus, for example, one counts the gamma emission at say one hour after injection of the isotope; repeat counts are then made at later times, say three hours and twenty-four hours, depending upon the isotope used. By this means Planiol has been able to achieve a high percentage of accuracy in differentiating three of the commonest massesastrocytomas, meningiomas and metastases.
Dr Douglas Gordon
(West End Hospital for Neurology and Neurosurgery, London)
The Limitations and Uses of Ultrasound in Localizing Cerebral Lesions
Though Dussik tried to demonstrate the ventricles with ultrasound as early as 1942, using a transmission technique, Howry in Denver, Colorado, was the first to apply the pulse-echo technique successfully in medicine. Howry described his work on soft tissues in 1952 but did not mention the application to the skull.
The first workers in Europe were Durden Smith and Walton, radiotherapists at the Royal Cancer Hospital, London, whose early efforts were developed by the physicists Turner and 'Spalding Smith at the same hospital. The exhibit at the Physical Society's Exhibition in 1954 was the first public demonstration of echoes from the brain through the unopened skull. The first paper to a medical audience was given at the Symposium Neuroradiologicum in London in
1955.
These and all other diagnostic techniques in clinical use are developments of the industrial flaw-detector used to test masses of metal nondestructively.
In the pulse-echo techniques it is necessary to produce a very short burst of ultrasonic activity so that the echo from one reflecting surface will die away before the echo from the next begins. This is achieved by applying a very sudden electrical potential to a crystal to produce stress in it and by damping it by a mechanical and an electrical load to cause the energy to be rapidly dissipated.
When an echo strikes a crystal, it produces a potential that follows the same outline when viewed on an oscilloscope as did the original transmission pulse, though of course the voltage is very much smaller. The simplest way to observe these pulses is in amplified but otherwise unchanged form (Fig 1A) .
The first modification is to rectify this alternating potential so that it appears as in Fig 1B. This 
